Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 135 (1) , 42-48
Abstract
Background & objectives: Chronic myelogenous leukaemia (CML) is the commonest leukaemia in Asia. There is a paucity data on cytogenetic and molecular analyses of Indian CML patients. This apparently reflects the low availability of cytogenetic and molecular techniques in our country. This study aimed to document various types of BCR-ABL fusion transcripts in different phases of CML and to compare the Ph chromosome positivity/negativity vis-a-vis BCR-ABL fusion transcripts in adult CML patients. Methods: Between June 2004 and February 2009, 208 patients were diagnosed as CML in chronic phase (CP), accelerated phase (AP) and blast crisis (BC), according to standard criteria. Cytogenetic and molecular genetic analyses were performed in all patients. Various types of BCR-ABL hybrid transcripts were compared with phases of CML and cytogenetic abnormalities. Results: Among 208 CML patients, b3a2 BCR-ABL transcripts were most commonly detected (66.82%) followed by b2a2 (28.84%), b3a2 + b2a2 (3.36%), b3a2 + e19a2 (0.48%) and b2a2 + e19a2 (0.48%). b3a2 transcripts were more frequently detected than b2a2 transcripts, in the whole group of 208 as well as in 183 CML-CP patients (PBCR-ABL transcript type. Interpretation & conclusions: This study documents higher Ph positivity (96.15%) by cytogenetic analysis among CML patients, as confirmed by qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis in a large patient group from north India. Both the techniques contribute towards understanding the disease biology, and have important implications for diagnosis and management of CML patients.Keywords
This publication has 23 references indexed in Scilit:
- Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcriptsAnnals of Hematology, 2009
- Chronic myeloid leukemia in AsiaInternational Journal of Hematology, 2008
- Analysis and comparison of clinicohematological parameters and molecular and cytogenetic response of two Bcr/Abl fusion transcriptsGenetics and Molecular Research, 2008
- Milestones and Monitoring in Patients with CML Treated with ImatinibHematology-American Society Hematology Education Program, 2008
- Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitorsAmerican Journal of Hematology, 2007
- Molecular profiling of chronic myeloid leukemia in eastern IndiaAmerican Journal of Hematology, 2006
- Comprehensive Validation of a Real-Time Quantitative bcr-abl Assay for Clinical Laboratory UseAmerican Journal of Clinical Pathology, 2003
- Expression of μ-BCR-ABLTranscripts in Chronic Neutrophilic LeukemiaAmerican Journal of Clinical Pathology, 2002
- Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisisLeukemia Research, 1994
- Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemiaCancer Genetics and Cytogenetics, 1991